Know Cancer

or
forgot password

Oral Cleft Prevention Trial in Brazil


Phase 3
16 Years
45 Years
Not Enrolling
Female
Cleft Lip, Cleft Palate

Thank you

Trial Information

Oral Cleft Prevention Trial in Brazil


Craniofacial anomalies and cleft lip with or without cleft palate (CL/P) are a model for the
impact of birth defects on fetal and neonatal health directly and maternal health
indirectly. Craniofacial anomalies comprise a significant component of morbid human birth
defects. The primary hypothesis is that folic acid supplementation of 4mg/day at
preconception and during the first three months of pregnancy will decrease the recurrence of
nonsyndromic cleft lip with or without clef palate (NSCL/P) in a high-risk group of women
when compared to women taking 0.4 mg per day of folic acid. The total sample will include
2,000 women (that either have NSCL/P or that have at least one child with NSCL/P) randomly
assigned to the 4 mg versus the 0.4 mg folic acid study groups. The study will also compare
the recurrence rates of NSCL/P in the total sample of subjects as well as the two study
groups (4mg, 0.4 mg) to that of a historical control group.

The primary outcome assessed is the rate of recurrences of NSCL/P in offspring of the trial
mothers in each of the two study groups. Secondary outcomes include recurrence of NSCL/P
compared to a historical control group; serum and red cell folate levels; severity of NSCL/P
in offspring of trial mothers; twinning rate; miscarriage rate; preeclampsia; rates of other
birth defects; birth weight; and gestational age. The sample size was based on historic
tables of birth rates and the rates of cleft occurrences. The study hypothesizes that a
total of 2000 subjects will be enrolled during a 2.5 year period; a dropout rate of 10%;
birth rate for group A (women with NSCL/P) of 10% and a rate of 12% for group B (women with
at least one child with NSCL/P); risk of cleft for group A is 7% and for group B is 4%;
one-sided test with continuity correction.


Inclusion Criteria:



- All women must reside in the state where the clinic is located.

- Women with NSCL/P who attend the craniofacial clinics, who are 16 to 45 years of age
(after age 45 fecundity decreases substantially)who attend the craniofacial clinic
for their care.

- Women (ages 16 to 45 years of age) who have at least one natural child of any age
with NSCL/P who receives care at the participating craniofacial clinics.

Exclusion Criteria:

- Cases resulting from consanguineous couples (first, second, and third degree, i.e.,
first cousins or closer).

- Couples where at least one of the two is definitely sterilized.

- Women on anti-epileptic drugs.

- Women who are pregnant.

- Women who are planning to move outside of the state where the clinic is located
within the next year.

- Women who are planning to move outside of Sao Paulo state within the next year.

- Women who have B12 deficiency (B12 level is below 174 pg/ml or 134.328 pmol/L).

- Women who have an allergy to folic acid.

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Prevention

Outcome Measure:

Recurrence of nonsyndromic cleft lip with or without cleft palate (NSCL/P) in offspring of trial mothers

Principal Investigator

Jeff Murray, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Iowa

Authority:

United States: Federal Government

Study ID:

GN 04 Aim III

NCT ID:

NCT00098319

Start Date:

January 2004

Completion Date:

April 2007

Related Keywords:

  • Cleft Lip
  • Cleft Palate
  • Cleft palate
  • Cleft lip
  • Folic acid
  • Global Network
  • Maternal and child health
  • International
  • Women's health
  • Brazil
  • Brasil
  • Latin America
  • ECLAMC
  • Congenital defects
  • Pregnancy
  • Cleft Lip
  • Cleft Palate

Name

Location